{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:01:52Z","timestamp":1771426912281,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-026-00833-0","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:25:06Z","timestamp":1769520306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An integrative analysis of genetic factors reveals dysregulation of cytokines, immune signaling, and T cell activity as the underlying immune mechanisms in autoimmune immune thrombocytopenia"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9021-2626","authenticated-orcid":false,"given":"Pratyusha","family":"Patidar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulika","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"4","key":"833_CR1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2141.2006.06024.x","volume":"133","author":"N Cooper","year":"2006","unstructured":"Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol. 2006;133(4):364\u201374.","journal-title":"Br J Haematol"},{"issue":"22","key":"833_CR2","first-page":"3308","volume":"124","author":"G Moulis","year":"2014","unstructured":"Moulis G, Palmaro A, Montastruc JL, Godeau B, Lapeyre-Mestre M, Sailler L. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood J Am Soc Hematol. 2014;124(22):3308\u201315.","journal-title":"Blood J Am Soc Hematol"},{"issue":"3","key":"833_CR3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjh.18886","volume":"202","author":"DA Lawrie","year":"2023","unstructured":"Lawrie DA, Mannering N, Hansen DL, Frederiksen H. Time trends in incidence and prevalence of immune thrombocytopenia: A nationwide cohort analysis. Br J Haematol. 2023;202(3):690\u20132.","journal-title":"Br J Haematol"},{"issue":"2","key":"833_CR4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13696998.2019.1669329","volume":"23","author":"D Weycker","year":"2020","unstructured":"Weycker D, Hanau A, Hatfield M, Wu H, Sharma A, Bensink ME, Chandler D, Grossman A, Tarantino M. Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis. J Med Econ. 2020;23(2):184\u201392.","journal-title":"J Med Econ"},{"issue":"14","key":"833_CR5","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1182\/bloodadvances.2023009949","volume":"7","author":"JA Georgi","year":"2023","unstructured":"Georgi JA, Middeke JM, Bornh\u00e4user M, Matzdorff A, Trautmann-Grill K. Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP. Blood Adv. 2023;7(14):3710\u201324.","journal-title":"Blood Adv"},{"issue":"4","key":"833_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139.","journal-title":"Nat Methods"},{"issue":"W1","key":"833_CR7","doi-asserted-by":"crossref","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"NL Sim","year":"2012","unstructured":"Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40(W1):W452\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"1620","key":"833_CR8","doi-asserted-by":"crossref","first-page":"20120362","DOI":"10.1098\/rstb.2012.0362","volume":"368","author":"AC Nica","year":"2013","unstructured":"Nica AC, Dermitzakis ET. Expression quantitative trait loci: present and future. Philosophical Trans Royal Soc B: Biol Sci. 2013;368(1620):20120362.","journal-title":"Philosophical Trans Royal Soc B: Biol Sci"},{"issue":"5","key":"833_CR9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41588-023-01365-3","volume":"55","author":"S Dong","year":"2023","unstructured":"Dong S, Zhao N, Spragins E, Kagda MS, Li M, Assis P, Jolanki O, Luo Y, Cherry JM, Boyle AP, Hitz BC. Annotating and prioritizing human non-coding variants with RegulomeDB v. 2. Nat Genet. 2023;55(5):724\u20136.","journal-title":"Nat Genet"},{"issue":"W1","key":"833_CR10","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, McDermott MG. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"833_CR11","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"833_CR12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s10038-023-01189-3","volume":"68","author":"MY Ang","year":"2023","unstructured":"Ang MY, Takeuchi F, Kato N. Deciphering the genetic landscape of obesity: a data-driven approach to identifying plausible causal genes and therapeutic targets. J Hum Genet. 2023;68(12):823\u201333.","journal-title":"J Hum Genet"},{"issue":"Suppl 4","key":"833_CR13","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"issue":"11","key":"833_CR14","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"D1","key":"833_CR15","doi-asserted-by":"crossref","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","volume":"52","author":"M Cannon","year":"2024","unstructured":"Cannon M, Stevenson J, Stahl K, Basu R, Coffman A, Kiwala S, McMichael JF, Kuzma K, Morrissey D, Cotto K, Mardis ER. DGIdb 5.0: rebuilding the drug\u2013gene interaction database for precision medicine and drug discovery platforms. Nucleic Acids Res. 2024;52(D1):D1227\u201335.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"833_CR16","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","volume":"44","author":"M Kuhn","year":"2016","unstructured":"Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2016;44(D1):D1075\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"833_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/21645515.2015.1059975","volume":"12","author":"X Guo","year":"2016","unstructured":"Guo X, Yasen H, Zhao F, Wang L, Sun M, Pang N, Wang X, Zhang Y, Ding J, Ma X. The effect of single course high dose dexamethasone on CD28\/CTLA-4 balance in the treatment of patients with newly diagnosed primary immune thrombocytopenia. Hum Vaccines Immunotherapeutics. 2016;12(1):97\u2013103.","journal-title":"Hum Vaccines Immunotherapeutics"},{"issue":"5\u20136","key":"833_CR18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1034\/j.1600-0609.2002.02774.x","volume":"69","author":"M Nagahama","year":"2002","unstructured":"Nagahama M, Nomura S, Kanazawa S, Ozaki Y, Kagawa H, Fukuhara S. Significance of chemokines and soluble CD40 ligand in patients with autoimmune thrombocytopenic purpura. Eur J Haematol. 2002;69(5\u20136):303\u20138.","journal-title":"Eur J Haematol"},{"issue":"4","key":"833_CR19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2008.07039.x","volume":"141","author":"VL Patel","year":"2008","unstructured":"Patel VL, Schwartz J, Bussel JB. The effect of anti-CD40 ligand in immune thrombocytopenic purpura. Br J Haematol. 2008;141(4):545\u20138.","journal-title":"Br J Haematol"},{"issue":"2","key":"833_CR20","first-page":"621","volume":"101","author":"M Kuwana","year":"2003","unstructured":"Kuwana M, Kawakami Y, Ikeda Y. Suppression of autoreactive T-cell response to glycoprotein IIb\/IIIa by Blockade of CD40\/CD154 interaction: implications for treatment of immune thrombocytopenic purpura. Blood J Am Soc Hematol. 2003;101(2):621\u20133.","journal-title":"Blood J Am Soc Hematol"},{"issue":"9","key":"833_CR21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.0000070111.98158.6C","volume":"92","author":"DP Inwald","year":"2003","unstructured":"Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circul Res. 2003;92(9):1041\u20138.","journal-title":"Circul Res"},{"key":"833_CR22","doi-asserted-by":"crossref","first-page":"825892","DOI":"10.3389\/fimmu.2022.825892","volume":"13","author":"F Cognasse","year":"2022","unstructured":"Cognasse F, Duchez AC, Audoux E, Ebermeyer T, Arthaud CA, Prier A, Eyraud MA, Mismetti P, Garraud O, Bertoletti L, Hamzeh-Cognasse H. Platelets as key factors in inflammation: focus on CD40L\/CD40. Front Immunol. 2022;13:825892.","journal-title":"Front Immunol"},{"key":"833_CR23","doi-asserted-by":"crossref","unstructured":"Nishimoto T, Kuwana M. CD4\u2009+\u2009CD25\u2009+\u2009Foxp3\u2009+\u2009regulatory T cells in the pathophysiology of immune thrombocytopenia. In: Seminars in Hematology. WB Saunders (ed). 2013;50:S43\u20139.","DOI":"10.1053\/j.seminhematol.2013.03.018"},{"issue":"6","key":"833_CR24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-008-9251-y","volume":"28","author":"YY Wan","year":"2008","unstructured":"Wan YY, Flavell RA. TGF-\u03b2 and regulatory T cell in immunity and autoimmunity. J Clin Immunol. 2008;28(6):647\u201359.","journal-title":"J Clin Immunol"},{"key":"833_CR25","unstructured":"Moncrieffe H. (2023). Regulatory T cells (Tregs). The British Society for Immunology. Retrieved from https:\/\/www.immunology.org\/public-information\/bitesized-immunology\/cells\/regulatory-t-cells-tregs"},{"issue":"2","key":"833_CR26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.thromres.2006.09.008","volume":"120","author":"M Sakakura","year":"2007","unstructured":"Sakakura M, Wada H, Tawara I, Nobori T, Sugiyama T, Sagawa N, Shiku H. Reduced Cd4\u2009+\u2009Cd25\u2009+\u2009T cells in patients with idiopathic thrombocytopenic purpura. Thromb Res. 2007;120(2):187\u201393.","journal-title":"Thromb Res"},{"issue":"8","key":"833_CR27","first-page":"493","volume":"22","author":"G Zhang","year":"2017","unstructured":"Zhang G, Zhang P, Liu H, Liu X, Xie S, Wang X, Wu Y, Chang J, Ma L. Assessment of Th17\/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model. Hematology. 2017;22(8):493\u2013500.","journal-title":"Hematology"},{"issue":"3","key":"833_CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12026-014-8620-2","volume":"61","author":"F Li","year":"2015","unstructured":"Li F, Ji L, Wang W, Hua F, Zhan Y, Zou S, Yuan L, Ke Y, Min Z, Song D, Sun L. Insufficient secretion of IL-10 by Tregs compromised its control on over-activated CD4\u2009+\u2009T effector cells in newly diagnosed adult immune thrombocytopenia patients. Immunol Res. 2015;61(3):269\u201380.","journal-title":"Immunol Res"},{"issue":"2","key":"833_CR29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/cei.12279","volume":"176","author":"RM Talaat","year":"2014","unstructured":"Talaat RM, Elmaghraby AM, Barakat SS, El-Shahat M. Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP). Clin Experimental Immunol. 2014;176(2):291\u2013300.","journal-title":"Clin Experimental Immunol"},{"key":"833_CR30","doi-asserted-by":"crossref","unstructured":"Lin X, Xu A, Zhou L, Zhao N, Zhang X, Xu J, Feng S, Zheng C. Imbalance of T lymphocyte subsets in adult immune thrombocytopenia. Int J Gen Med. 2021 Mar;18:937\u201347.","DOI":"10.2147\/IJGM.S298888"},{"issue":"7","key":"833_CR31","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00431-023-04945-x","volume":"182","author":"M Zakaria","year":"2023","unstructured":"Zakaria M, Beshir M, Hassan T, Esh A, Abdelaziz E, Tayib R, Nafea A. Role of Interleukin 4 (IL4) and Interleukin 6 (IL6) in the pathogenesis and prognosis of childhood primary immune thrombocytopenia. Eur J Pediatrics. 2023;182(7):3129\u201338.","journal-title":"Eur J Pediatrics"},{"issue":"1","key":"833_CR32","first-page":"589672","volume":"2014","author":"S Oh","year":"2014","unstructured":"Oh S, Hwang ES. The role of protein modifications of T-bet in cytokine production and differentiation of T helper cells. J Immunol Res. 2014;2014(1):589672.","journal-title":"J Immunol Res"},{"issue":"2","key":"833_CR33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/09537100903420277","volume":"21","author":"H Zhao","year":"2010","unstructured":"Zhao H, Du W, Wang D, Gu D, Xue F, Ge J, Sui T, Yang R. The expression of IFN-\u03b3, IL-4, Foxp3 and Perforin genes are not correlated with DNA methylation status in patients with immune thrombocytopenic purpura. Platelets. 2010;21(2):137\u201343.","journal-title":"Platelets"},{"issue":"4","key":"833_CR34","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pbc.22984","volume":"57","author":"JD Wang","year":"2011","unstructured":"Wang JD, Chang TK, Lin HK, Huang FL, Wang CJ, Lee HJ. Reduced expression of transforming growth factor-\u03b21 and correlated elevation of interleukin\u201017 and interferon\u2010\u03b3 in pediatric patients with chronic primary immune thrombocytopenia (ITP). Pediatr Blood Cancer. 2011;57(4):636\u201340.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"833_CR35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.2023022738","volume":"144","author":"L Wang","year":"2024","unstructured":"Wang L, Wang H, Zhu M, Ni X, Sun L, Wang W, Xie J, Li Y, Xu Y, Wang R, Han S. Platelet-derived TGF-\u03b21 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia. Blood. 2024;144(1):99\u2013112.","journal-title":"Blood"},{"issue":"2","key":"833_CR36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/bjh.13126","volume":"168","author":"H Zhong","year":"2015","unstructured":"Zhong H, Bussel J, Yazdanbakhsh K. In vitro TNF Blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia. Br J Haematol. 2015;168(2):274\u201383.","journal-title":"Br J Haematol"},{"key":"833_CR37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coi.2018.09.002","volume":"55","author":"BE Jones","year":"2018","unstructured":"Jones BE, Maerz MD, Buckner JH. IL-6: a cytokine at the crossroads of autoimmunity. Curr Opin Immunol. 2018;55:9\u201314.","journal-title":"Curr Opin Immunol"},{"issue":"7090","key":"833_CR38","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235\u20138.","journal-title":"Nature"},{"issue":"5","key":"833_CR39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MBC.0000000000000742","volume":"29","author":"Y Ke","year":"2018","unstructured":"Ke Y, Li F, Zhan Y, Wu B, Zou S, Ji L, Min Z, Hou J, Sun L, Chen H, Cheng Y. Aberrant phosphorylation of signal transducer and activator of transcription 3 protein of the CD4\u2009+\u2009T cells in patients with primary immune thrombocytopenia. Blood Coagul Fibrinolysis. 2018;29(5):458\u201364.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"833_CR40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.thromres.2020.04.004","volume":"190","author":"J Li","year":"2020","unstructured":"Li J, Hua M, Hu X, Zhang Y, Feng Q, Qiu J, Shao L, Li N, Hou M, Peng J. Dexamethasone suppresses the Th17\/1 cell polarization in the CD4\u2009+\u2009T cells from patients with primary immune thrombocytopenia. Thromb Res. 2020;190:26\u201334.","journal-title":"Thromb Res"},{"issue":"42","key":"833_CR41","doi-asserted-by":"crossref","first-page":"16975","DOI":"10.1073\/pnas.1315862110","volume":"110","author":"Y Wang","year":"2013","unstructured":"Wang Y, van Boxel-Dezaire AH, Cheon H, Yang J, Stark GR. STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor. Proc Natl Acad Sci. 2013;110(42):16975\u201380.","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"833_CR42","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","volume":"2","author":"S Akira","year":"2001","unstructured":"Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2(8):675\u201380.","journal-title":"Nat Immunol"},{"issue":"2","key":"833_CR43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.thromres.2013.04.025","volume":"132","author":"H Liu","year":"2013","unstructured":"Liu H, Ouyang X, Li Y, Zeng H, Wang X, Xie S, Nie D, Xiao J, Wei J, Wu Y, Yin S. Involvement of levels of toll like receptor-4 in monocytes, CD4\u2009+\u2009T-lymphocyte subsets, and cytokines in patients with immune thrombocytopenic purpura. Thromb Res. 2013;132(2):196\u2013201.","journal-title":"Thromb Res"},{"key":"833_CR44","unstructured":"Cheng Y, Zou S, Li F. Increased expression of TLR2 and TLR4 in mononuclear cells in patient with immune thrombocytopenic purpura."},{"issue":"5","key":"833_CR45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/08916934.2017.1309034","volume":"50","author":"Y Hao","year":"2017","unstructured":"Hao Y, Li H, Li Y, Lyu M, Zhang D, Fu R, Guan Y, Wang S, Sun B, Dou X, Yang R. Decreased TLR4 expression on monocytes May cause regulatory T cells abnormality in patients with primary immune thrombocytopenia. Autoimmunity. 2017;50(5):283\u201392.","journal-title":"Autoimmunity"},{"issue":"7","key":"833_CR46","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2005-03-0916","volume":"106","author":"G Andonegui","year":"2005","unstructured":"Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional Toll-like receptor-4. Blood. 2005;106(7):2417\u201323.","journal-title":"Blood"},{"key":"833_CR47","doi-asserted-by":"crossref","unstructured":"Ng AP, Kauppi M, Metcalf D, Hyland CD, Josefsson EC, Lebois M, Zhang JG, Baldwin TM, Di Rago L, Hilton DJ, Alexander WS. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation. Proceedings of the National Academy of Sciences. 2014;111(16):5884-9.","DOI":"10.1073\/pnas.1404354111"},{"issue":"6","key":"833_CR48","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3324\/haematol.2018.212845","volume":"104","author":"W Ghanima","year":"2019","unstructured":"Ghanima W, Cooper N, Rodeghiero F, Godeau B, Bussel JB. Thrombopoietin receptor agonists: ten years later. Haematologica. 2019;104(6):1112.","journal-title":"Haematologica"},{"issue":"1","key":"833_CR49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s44337-024-00008-8","volume":"1","author":"S Tungjitviboonkun","year":"2024","unstructured":"Tungjitviboonkun S, Bumrungratanayos N. Immune thrombocytopenia (ITP): historical perspectives, pathophysiology, and treatment advances. Discover Med. 2024;1(1):7.","journal-title":"Discover Med"},{"issue":"5","key":"833_CR50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/17512433.2021.1903315","volume":"14","author":"R Sandal","year":"2021","unstructured":"Sandal R, Mishra K, Jandial A, Sahu KK, Siddiqui AD. Update on diagnosis and treatment of immune thrombocytopenia. Expert Rev Clin Pharmacol. 2021;14(5):553\u201368.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"833_CR51","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s12185-022-03492-9","volume":"117","author":"Y Nakamura","year":"2023","unstructured":"Nakamura Y, Itoh Y, Wakimoto N. Improvement of immune thrombocytopenia with Imatinib therapy following chronic myeloid leukemia. Int J Hematol. 2023;117(4):613\u20137.","journal-title":"Int J Hematol"},{"key":"833_CR52","first-page":"bcr2016215888","volume":"2017","author":"TB Mortensen","year":"2017","unstructured":"Mortensen TB, Frederiksen H, Marcher CW, Preiss B. Refractory primary immune thrombocytopenia with subsequent Del (5q) MDS: complete remission of both after Lenalidomide. Case Rep. 2017;2017:bcr2016215888.","journal-title":"Case Rep"},{"issue":"5","key":"833_CR53","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1200\/JCO.2013.51.0057","volume":"34","author":"MR Grunwald","year":"2016","unstructured":"Grunwald MR, Spivak JL. Ruxolitinib enhances platelet production in patients with thrombocytopenic myelofibrosis. J Clin Oncol. 2016;34(5):e38\u201340.","journal-title":"J Clin Oncol"},{"key":"833_CR54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.intimp.2019.04.041","volume":"72","author":"ZG Yang","year":"2019","unstructured":"Yang ZG, Wen RT, Zhang YM, Wu GC, Chen WJ, Wang YF, Weng ZY, Wen SS, Zhang XJ, Guan MH. Thalidomide induce response in patients with corticosteroid-resistant or relapsed ITP by upregulating Neuropilin-1 expression. Int Immunopharmacol. 2019;72:437\u201344.","journal-title":"Int Immunopharmacol"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-026-00833-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00833-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00833-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:02:31Z","timestamp":1771423351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-026-00833-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1186\/s12959-026-00833-0","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}